Nestle just rolled out a new protein shot drink that it says will help people looking to lose weight manage their hunger and ...

SIGN UP for TheStreet’s FREE Daily newsletter 💰💸 With the growing popularity of weight loss drugs like Ozempic, Wegovyn, ...

A UCLA student is suing multiple California health care providers and hospitals for medical negligence, alleging she was ...

The U.S. Food and Drug Administration reissued a decision first made by the agency in October that a shortage of the diabetes ...

News of Merck’s licensing of Hansoh’s preclinical medicine pressured shares in Viking and other obesity drug developers seen ...

Henrik Wulff, the man in charge of product supply at Novo Nordisk, just spent $11 billion to try to fill an ocean. Novo has ...

Hims & Hers faces regulatory hurdles but shows strong business growth. Find out why HIMS stock is a "Hold" despite setbacks ...

As the festive season approaches, experts have a warning for those taking prescription GLP-1 receptor agonist drugs.

Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for ...

GLP-1 drugs are remarkably effective at addressing obesity, cardiovascular, and metabolic conditions, but investigators ...

Novo Nordisk’s latest attempt in weight loss, a combination drug called CagriSema, matched the bar set by Lilly’s currently ...

The marketing initiative touts the protein and fiber content, which appeals to consumers taking weight-loss medications such ...